GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biome Grow Inc (OTCPK:BIOIF) » Definitions » Equity-to-Asset

Biome Grow (Biome Grow) Equity-to-Asset : -37.09 (As of Sep. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Biome Grow Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Biome Grow's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $-3.56 Mil. Biome Grow's Total Assets for the quarter that ended in Sep. 2023 was $0.10 Mil.

The historical rank and industry rank for Biome Grow's Equity-to-Asset or its related term are showing as below:

BIOIF' s Equity-to-Asset Range Over the Past 10 Years
Min: -37.07   Med: 0.65   Max: 1
Current: -37.07

During the past 10 years, the highest Equity to Asset Ratio of Biome Grow was 1.00. The lowest was -37.07. And the median was 0.65.

BIOIF's Equity-to-Asset is ranked worse than
99.26% of 1085 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs BIOIF: -37.07

Biome Grow Equity-to-Asset Historical Data

The historical data trend for Biome Grow's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biome Grow Equity-to-Asset Chart

Biome Grow Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.96 0.51 0.52 0.58 -9.54

Biome Grow Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.86 -1.56 -9.54 -12.77 -37.09

Competitive Comparison of Biome Grow's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Biome Grow's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biome Grow's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biome Grow's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Biome Grow's Equity-to-Asset falls into.



Biome Grow Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Biome Grow's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Equity to Asset (A: Dec. 2022 )=Total Stockholders Equity/Total Assets
=-3.254/0.341
=

Biome Grow's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )=Total Stockholders Equity/Total Assets
=-3.561/0.096
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biome Grow  (OTCPK:BIOIF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Biome Grow Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Biome Grow's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Biome Grow (Biome Grow) Business Description

Traded in Other Exchanges
Address
480 University Avenue, Suite 1401, Toronto, ON, CAN, M5G 1V2
Biome Grow Inc is a Canada-based company engaged in medical and recreational cannabis businesses. Along with its subsidiaries, the firm is engaged in the cultivation of marijuana plants, dried marijuana and marijuana seeds. The company through its Weed VR platform connects customers with growers and distributors as well as retail partners.

Biome Grow (Biome Grow) Headlines

From GuruFocus

Biome Grow Announces Supply Agreement With Cannabis NB

By Marketwired Marketwired 08-12-2019

Biome Opens the Door to U.S. Investors -- CFN Media

By Marketwired Marketwired 01-15-2019

Biome Announces OTCQB Listing

By Marketwired Marketwired 01-02-2019

Biome Grow Wins Right to Sell Cannabis in Manitoba

By Marketwired Marketwired 08-14-2019